Abstract
Current treatment choices for intrahepatic cholestasis are rather limited. Ursodiol is used in the management of cholestasis resulting from primary biliary cirrhosis, and can also be considered in the management of primary sclerosing cholangitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote J. Primary biliary cirrhosis. Hepatology. 2009;50(1):291–308.
Lindor KD, Kowdley KV, Harrison ME. ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015;110:646–59.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bath, R.K. (2016). Cholestasis. In: Wu, G. (eds) Pocket Handbook of GI Pharmacotherapeutics. Clinical Gastroenterology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-33317-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-33317-5_10
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-33315-1
Online ISBN: 978-3-319-33317-5
eBook Packages: MedicineMedicine (R0)